Differences in O2 reduction by the iron complexes of adriamycin and daunomycin: the importance of the sidechain hydroxyl group
Authors:
- Jay L. ZweierJZJay L. Zweier
- Luca GianniLuca Gianni
- Josephia MuindiJMJosephia Muindi
- Charles E. MyersCMCharles E. Myers
- 1 November 1986
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 884 (2) , 326-336
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Iron-mediated formation of an oxidized adriamycin free radicalBiochimica et Biophysica Acta (BBA) - General Subjects, 1985
- Iron(III)-adriamycin and iron(III)-daunorubicin complexes: physicochemical characteristics, interaction with DNA, and antitumor activityBiochemistry, 1985
- Hydroxyl radical production and DNA damage induced by anthracycline‐iron complexFEBS Letters, 1984
- Oxidative destruction of DNA by the adriamycin-iron complexBiochemistry, 1984
- Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complexBiochemistry, 1982
- The Anthracycline Antineoplastic DrugsNew England Journal of Medicine, 1981
- Enzymatic Defenses of the Mouse Heart Against Reactive Oxygen MetabolitesJournal of Clinical Investigation, 1980
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- Daunomycin-induced cardiotoxicity in children and adultsThe American Journal of Medicine, 1977